Skip to main content
. 2020 Apr 21;13:761–770. doi: 10.2147/JPR.S214488

Table 1.

Descriptive Statistics of the Studied Variables Measured in the Sample at Baseline (T0) and After 30 Days of Treatment (T2)

N=50 (20 Males):
(Mean Age 62.46±8.45 SD):
(Mean Height 1.62±0.10 SD):
Baseline (t0):
Mean±SD:
After 30 Days (t2):
Mean±SD:
BMI (kg/m2) 28.26±3.71 26.93±6.44
Fat-free mass (g) 43,317.86±8812.937 43,535.31±8991.567
Fat mass (g) 29,387.54±12,330.77 28,420.94±11,485.22
VAT (g) 2029.36±5895.902 2029.625±5978.721
ESR (mm/h) 24.78±13.65 21.64±14.85
CRP (mg/L) 0.33±0.65 0.21±0.47
SF-36
Physical activity 74.5±23.54 78.96±22.51
Role limitations due to physical health 58.08±36.67 63.16±33.97
Pain 50.68±28.18 54.55±30.81
General health 53.68±16.91 53.84±17.87
Vitality 53.76±15.08 54.94±16.39
Social functioning 62.36±19.97 63.94±23.44
Role limitations due to emotional problems 66.48±33.31 71.92±30.71
Emotional well-being 63.38±29.31 61.64±29.39

Abbreviations: BMI, body mass index; VAT, visceral fat; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; SF-36, Short Form36; SD, standard deviation.